SecSonar.com

Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Actinium Pharmaceuticals, Inc. (ATNM) is a Biotechnology company based in US with a market capitalization of $38.9M. Free cash flow was negative at -$24.7M. This page tracks ATNM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 31 employees · IPO Dec 27, 2012

Valuation

Valuation & price

$1.25 · as of May 17, 2026 · -33.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.97

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.87$1.43$0.99Jul 25Dec 25Jun 26Jul 7, 25$1.42Jul 9, 25$1.58Jul 11, 25$1.52Jul 15, 25$1.49Jul 17, 25$1.62Jul 21, 25$1.69Jul 23, 25$1.87Jul 25, 25$1.79Jul 29, 25$1.61Jul 31, 25$1.63Aug 4, 25$1.66Aug 6, 25$1.60Aug 8, 25$1.54Aug 12, 25$1.51Aug 14, 25$1.65Aug 18, 25$1.71Aug 20, 25$1.64Aug 22, 25$1.74Aug 26, 25$1.78Aug 28, 25$1.74Sep 3, 25$1.71Sep 5, 25$1.58Sep 9, 25$1.60Sep 11, 25$1.68Sep 15, 25$1.62Sep 17, 25$1.61Sep 19, 25$1.59Sep 23, 25$1.62Sep 25, 25$1.59Sep 29, 25$1.62Oct 1, 25$1.60Oct 3, 25$1.58Oct 7, 25$1.58Oct 9, 25$1.50Oct 13, 25$1.61Oct 15, 25$1.55Oct 17, 25$1.46Oct 21, 25$1.51Oct 23, 25$1.43Oct 27, 25$1.53Oct 30, 25$1.42Nov 3, 25$1.38Nov 5, 25$1.34Nov 7, 25$1.26Nov 11, 25$1.31Nov 13, 25$1.25Nov 17, 25$1.45Nov 19, 25$1.36Nov 21, 25$1.33Nov 25, 25$1.40Nov 28, 25$1.38Dec 2, 25$1.38Dec 4, 25$1.45Dec 8, 25$1.40Dec 10, 25$1.42Dec 12, 25$1.51Dec 16, 25$1.52Dec 18, 25$1.59Dec 22, 25$1.60Dec 24, 25$1.59Dec 29, 25$1.42Jan 2, 26$1.37Jan 6, 26$1.43Jan 8, 26$1.43Jan 12, 26$1.30Jan 14, 26$1.33Jan 16, 26$1.33Jan 21, 26$1.32Jan 23, 26$1.30Jan 27, 26$1.29Jan 29, 26$1.23Feb 2, 26$1.22Feb 4, 26$1.16Feb 6, 26$1.15Feb 10, 26$1.14Feb 12, 26$1.11Feb 17, 26$1.08Feb 19, 26$1.11Feb 23, 26$1.05Feb 25, 26$1.14Mar 2, 26$1.14Mar 4, 26$1.23Mar 6, 26$1.20Mar 10, 26$1.21Mar 12, 26$1.13Mar 16, 26$1.11Mar 18, 26$1.10Mar 20, 26$1.11Mar 24, 26$1.07Mar 26, 26$1.05Mar 30, 26$0.99Apr 1, 26$0.99Apr 6, 26$1.09Apr 8, 26$1.17Apr 10, 26$1.08Apr 14, 26$1.10Apr 16, 26$1.25Apr 20, 26$1.44Apr 22, 26$1.40Apr 24, 26$1.28Apr 28, 26$1.19May 1, 26$1.13May 5, 26$1.26May 7, 26$1.22May 11, 26$1.34May 13, 26$1.29May 15, 26$1.25May 19, 26$1.15May 21, 26$1.18May 26, 26$1.16May 28, 26$1.15Jun 1, 26$1.18Jun 3, 26$1.16Jun 5, 26$1.08Jun 9, 26$1.01Jun 11, 26$1.04Jun 15, 26$1.00Jun 17, 26$1.02Jun 22, 26$1.03Jun 26, 26$0.99
$0.9552-week range$1.87
Loading valuation history…

Fundamentals

Key fundamentals

$38.9M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$24.7M

Free cash flow (USD)

-$46.3M

Net debt

Net cash position

3.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$1.1MFY 2022$1.0MFY 2023$81.0KFY 2024$0.00FY 2025$90.0K
$0$90K

Free cash flow by year

2016 → 2025

FY 2016$-20.8MFY 2017$-21.6MFY 2018$-20.7MFY 2019$-21.5MFY 2020$-21.9MFY 2021$-21.0MFY 2022$8.3MFY 2023$-47.5MFY 2024$-33.1MFY 2025$-24.7M
-$20.8M-$24.7M

Gross margin by year

2021 → 2025

FY 202154.2%FY 2022100.0%FY 2023100.0%FY 2025100.0%
54.2%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCompliance Plan SubmittedJun 18, 2026Filing
  • 8-K eventDelisting NoticeMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing

Questions

Frequently asked questions

What is Actinium Pharmaceuticals, Inc.'s market cap?

Actinium Pharmaceuticals, Inc. (ATNM) has a market capitalization of $38.9M.

What is ATNM's P/E ratio?

A meaningful P/E ratio is not available for ATNM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ATNM's price-to-book (P/B) ratio?

ATNM trades at 4.97 times book value per share.

Are insiders buying ATNM stock?

SEC Form 4 filings show no open-market insider buys at Actinium Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

VERU

Veru Inc.

$37.4M

BTAI

BioXcel Therapeutics, Inc.

$37.1M

ATHE

Alterity Therapeutics Limited

$36.5M

INMB

INmune Bio, Inc.

$36.3M

NTRB

Nutriband Inc.

$41.6M

ALGS

Aligos Therapeutics, Inc.

$35.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.